BPC-157 hasn't been approved by the FDA. But that hasn't stopped this buzzy drug from gaining traction – and attention from MAHA.
TB-500 (a fragment of Thymosin Beta-4) and BPC-157 (Body Protection Compound) are two naturally derived peptide chains that have been the subject of significant academic interest. Each has been ...